Therapeutic Category
Diabetes Care
A complete diabetes management range: biguanides, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors and fixed-dose combinations, plus injectable options — supporting national NCD programs and hospital formularies.
We structure our diabetes portfolio around real prescribing patterns in emerging markets: metformin as the anchor, cost-effective sulfonylureas, and newer gliptin and gliflozin classes as economies shift toward premium generics. Extended-release formats and patient-friendly combination packs are available for chronic-care programs.
Representative molecules
A sample of the range — the complete list with strengths and pack sizes is in the category catalogue.
- Metformin
- Glimepiride
- Sitagliptin
- Dapagliflozin
- Vildagliptin + Metformin
- Insulin (partner-sourced)
Dosage forms
Category highlights
- Anchor + premium generic mix
- Chronic-care packaging options
- High-volume tender experience
Enquire about this category
Quotation within two business days, with registration guidance for your market.
Ready to discuss your market?
Send us your product list, tender specification or private-label brief. A senior export manager — not a chatbot — replies within one business day.
Or message our export desk on WhatsApp